DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising developments throughout numerous healthcare and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, far more trusted alternate for therapeutic use, spe